Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-11-01 00:00:00 ET · period of report 2024-10-30 · accession 0000950170-24-120099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-01 | 2024-10-30 | TYRA | Fuhrman Alan | CFO | P - Purchase | $16.00 | +9,500 | 12.8K | +284% | +$152.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-30 | P | A | 9,500 | $16.00 | 12,849 | D | — | — | (F1) Represents the weighted average price for the entire number of shares purchased. The actual prices range between $15.95 to $16.00. Detailed information on the exact number of shares purchased at each price can be obtained from the Issuer upon request. |